Abiopharma

📋 NANNINGA CHERRIE (Director) plans to sell 14K shares of LIFETIME BRANDS, INC (at $9.17 each, total $129K) Filed: Aug 24, 2026 | ID: 000536

New Form 424B2 - CITIGROUP INC <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0000950103-26-012788 <b>Size:</b> 335 KB

ZoomInfo Announces Updates to ZoomInfo MCP on Salesforce&apos;s AgentExchange

(10% Negative) UFP TECHNOLOGIES INC (UFPT) Files Form 8-K

New Form 424B2 - BARCLAYS BANK PLC <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0001918704-26-024556 <b>Size:</b> 590 KB

Real Estate Split Corp. Class A Distribution

New Form FWP - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0001839882-26-041180 <b>Size:</b> 136 KB

Greenland Mines Delivers Landmark S-K 1300 Mineral Resource Estimate for Sarfartoq in Greenland; First-Ever Indicated Resource and First Combined Open Pit/Underground Resource for the Critical Nd-Pr Magnet Rare Earths Project

GTM Investors Have Opportunity to Lead ZoomInfo Technologies Inc. Securities Fraud Lawsuit with SBS Law

BTU Investors Have Opportunity to Lead Peabody Energy Corporation Securities Fraud Lawsuit with SBS Law

New Form 424B2 - BANK OF NOVA SCOTIA <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0001839882-26-041178 <b>Size:</b> 321 KB

New Form 424B2 - BANK OF AMERICA CORP /DE/ <b>Filed:</b> 2026-08-24 <b>AccNo:</b> 0001918704-26-024555 <b>Size:</b> 522 KB

KLX Energy Services Holdings, Inc. - Rights (KLXER) was added to the exchange traded list on NASDAQ

Clinical trial NCT03054519: enrollment: 203 → 202 participants.

Clinical trial NCT05157672: status: UNKNOWN → COMPLETED.